Search Login Register

1,3-dipropyl-8-(3-noradamantyl)xanthine Summary

Description: selective antagonist for adenosine receptors; a cardiovascular agent

Also Known As: 1,3-DNAX; 8-(3-noradamantyl)-1,3-dipropylxanthine; 8-(noradamantan-3-yl)-1,3-dipropylxanthine; KW 3902; KW-3902 Show All >>

Networked: 41 relevant articles (8 outcomes, 15 trials/studies) for this Bio-Agent

Key Diseases for which 1,3-dipropyl-8-(3-noradamantyl)xanthine is Relevant

  1. Acute Kidney Injury (Acute Renal Failure) : 5 outcomes 1 study in 8 results
  2. Heart Failure : 4 outcomes 14 studies in 26 results
  3. Dyspnea (Shortness of Breath) : 1 outcome in 3 results
  4. Anoxia (Hypoxia) : 3 results
  5. Seizures (Seizure) : 2 results
Show All >>

Drugs Related to 1,3-dipropyl-8-(3-noradamantyl)xanthine

  1. Adenosine
  2. Purinergic P1 Receptors (Adenosine Receptor)
  3. Relaxin
  4. Brain Natriuretic Peptide (Natrecor)
  5. Vasopressins (Vasopressin)
  6. tolvaptan
  7. Glycerol (Glycerine)
  8. Gentamicins (Gentamicin)
  9. Contrast Media
  10. Cisplatin (Platino)
Show All >>

Therapies Related to 1,3-dipropyl-8-(3-noradamantyl)xanthine

  1. Injections
  2. Stents
  3. Drug-Eluting Stents

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.